Close

Gynecology

Protocols

Ovarian

GOBEP
Therapy of Non-Dysgerminomatous Ovarian Germ Cell Cancer Using Bleomycin, Etoposide and CISplatin


GOEP

Therapy of Non-Dysgerminomatous Ovarian Germ Cell Cancer Using Etoposide and CISplatin


GOOVAI

Therapy for Advanced Ovarian Cancer Using an Aromatase Inhibitor


GOOVCADM

Primary Treatment of Invasive Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer, with No Visible Residual Tumour (Moderate-High Risk) Using CARBOplatin and DOCEtaxel


GOOVCADR

Second Line Treatment Using DOCEtaxel and CARBOplatin for Epithelial Ovarian Cancer Relapsing after Primary Treatment


GOOVCADX

Primary Treatment of Visible Residual (Extreme Risk) Invasive Epithelial Ovarian Cancer Using CARBOplatin and DOCEtaxel


GOOVCAG

Treatment of Advanced Ovarian Cancer in Patients Who Have Progressed or Recurred Following First-line Platinum-Based Treatment Using CARBOplatin and Gemcitabine


GOOVCARB

First or Second Line Therapy for Invasive Epithelial Ovarian Cancer Using Single-Agent CARBOplatin


GOOVCATM

Primary Treatment of Invasive Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer, with No Visible Residual Tumour (Moderate-High Risk) Using CARBOplatin and PACLitaxel


GOOVCATR

Second Line Treatment Using PACLitaxel and CARBOplatin for Epithelial Ovarian Cancer Relapsing After Primary Treatment


GOOVCATX

Primary Treatment of Visible Residual (Extreme Risk) Invasive Epithelial Ovarian Cancer in Ambulatory Care Settings Using PACLitaxel and CARBOplatin


GOOVCIS

Therapy for Invasive Epithelial Ovarian Cancer using CISplatin


GOOVDDCAT

Treatment Of Advanced Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using CARBOplatin and Weekly PACLitaxel


GOOVDOC

Treatment of Progressive, Platinum-Refractory Epithelial Ovarian Carcinoma, Primary Peritoneal Carcinoma or Fallopian Tube Carcinoma Using DOCEtaxel


GOOVETO

Treatment of Relapsed/Progressing Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using Etoposide


GOOVGEM

Palliative Chemotherapy for Re-treatment of Ovarian, Tubal, and Peritoneal Cancer Using Gemcitabine


GOOVIPPC

BCCA Protocol Summary for Primary Treatment of Stage III less than or equal to 1 cm Visible Residual Invasive Epithelial Ovarian Cancer or Stage 1 Grade 3 or Stage II Grade 3 Papillary Serous Ovarian Cancer Using Intravenous and Intraperitoneal PACLitaxel and Intraperitoneal CARBOplatin


GOOVLDOX

Treatment of Relapsed/Progressing, Epithelial Ovarian, Primary Peritoneal Or Fallopian Tube Carcinoma Using Pegylated Liposomal DOXOrubicin


GOOVPLDC

Second Line Treatment for Epithelial Ovarian Cancer Relapsing After Primary Treatment Using Pegylated Liposomal DOXOrubicin (PLD) and CARBOplatin


GOOVTAM

Therapy for Advanced Ovarian Cancer Using Tamoxifen


GOOVTAX3

Treatment of Progressive, Platinum-refractory Epithelial Ovarian Carcinoma, Primary Peritoneal Carcinoma or Fallopian Tube Carcinoma Using PACLitaxel


GOOVTOP

Treatment of Relapsed/Progressive Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer Using Topotecan


GOOVVIN

Palliative Chemotherapy for Re-treatment of Ovarian, Tubal, and Peritoneal Cancer Using Vinorelbine

Cervical

GOCXAJCAT

Primary Adjuvant Treatment of Adenocarcinoma/Adenosquamous Cancer of the Cervix with CARBOplatin and PACLitaxel Prior to Irradiation with or without CISplatin


GOCXCAD

Treatment of Advanced/Recurrent Non-Small Cell Cancer of the Cervix with CARBOplatin and DOCEtaxel in Ambulatory Care Settings


GOCXCAT

Primary Treatment of Advanced/Recurrent Non-Small Cell Cancer of the Cervix with CARBOplatin and PACLitaxel in Ambulatory Care Settings


UGOCXCATB

Primary Treatment of Metastatic or Recurrent Squamous Cancer of the Cervix with Bevacizumab, CARBOplatin and PACLitaxel


GOCXCRT

Treatment of High Risk Squamous Carcinoma, Adenocarcinoma, or Adenosquamous Carcinoma of the Cervix with Concurrent CISplatin and Radiation

Endometrial

GOENDAI

Advanced Therapy for Endometrial Cancer using an Aromatase Inhibitor


GOENDCAD

Treatment of Primary Advanced or Recurrent Endometrial Cancer using CARBOplatin and DOCEtaxel


GOENDCAT

Treatment of Primary Advanced or Recurrent Endometrial Cancer using CARBOplatin and PACLitaxel


GOENDD

DOXOrubicin for Use in Patients with Advanced Endometrial Cancer

GOENDH

Non-Aromatase Inhibitor Hormonal Treatment of Endometrial Cancer

Other

  • GOSAD

  • DOXOrubicin for Use in Patients with Advanced Uterine Sarcoma

  • GOSADG

    Treatment of Uterine Sarcoma Cancer using DOCEtaxel and Gemcitabine


    GOSMCCRT

    Treatment of Small Cell or Neuroendocrine Carcinoma of Gynecologic System Origin using PACLitaxel, CISplatin, Etoposide and CARBOplatin with Radiation



    UGOTDHR

    Therapy for High Risk Gestational Trophoblastic (GO9103) "MACE" Using CISplatin, Etoposide, Dactinomycin, Methotrexate and Leucovorin


    GOTDLR

    Therapy for Low Risk Gestational Trophoblastic Neoplasia (GO 94 02) Using Methotrexate, Leucovorin and Actinomycin D

    Terms of use

    The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. 

    Use of these documents is at your own risk and is subject to the BC Cancer Agency's Terms of Use.

    Tab Heading
    Tab Heading
    SOURCE: Gynecology ( )
    Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

    Copyright © BC Cancer Agency. All Rights Reserved.

      Copyright © 2015 Provincial Health Services Authority